Drug Database
Back to search

Netherlands· NL-f1bb33f29167

Emadine 0,05% g/v, oogdruppels, oplossing

A emedastine product containing emedastine difumaraat, registered in Netherlands by Immedica Pharma AB. The same ATC class is registered in 12 of our 19 countries.

ATC S01GX06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEmadine 0,05% g/v, oogdruppels, oplo…ATCS01GX06REGISTER NO.NL-f1bb33f29167PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about emedastine difumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emedastine is registered in 12 of 19 countries.

Countries holding a registration under ATC S01GX06 (emedastine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search emedastine products by name

Emedastine · ATC S01GX06

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EMEDASTINE DIFUMARAAT
Manufacturer
Immedica Pharma AB
Country
Netherlands (NL)
ATC code
S01GX06
ATC class
Emedastine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/98/095

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under S01GX06

Emedastine, as other registers publish it.

All emedastine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c145bf87-304a-4ef2-8e7a-93fc62058eef
GET /v1/drugs/c145bf87-304a-4ef2-8e7a-93fc62058eef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/emadine-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Emedastine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70384",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "HYPROMELLOSE (E 464)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "TROMETAMOL",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "EMEDASTINE DIFUMARAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "1999/01/27",
  "procedure_number": "EMEA/H/C/000223",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/98/095",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about emedastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console